| European Case Law Identifier: | ECLI:EP:BA:2009:T072505.20091014 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 14 October 2009 | ||||||||
| Case number: | T 0725/05 | ||||||||
| Application number: | 95105609.2 | ||||||||
| IPC class: | C07K 16/46 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Production of Humanized Immunoglobulins and Corresponding Polynucleotiodies | ||||||||
| Applicant name: | PDL BioPharma, Inc. | ||||||||
| Opponent name: | (02) Boehringer Ingelheim GmbH (03) Medimmune, Inc. (04) Schering Corporation (05) CELLTECH R & D LIMITED (06) XOMA(US)LLC (07) Novartis AG (08) IDEC Pharmaceuticals Corpn |
||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Substantial procedural violation, remittal, reimbursement of the appeal fee, referral of questions to the EBA - (no) First auxiliary request - added subject-matter - (yes) Second auxiliary request - admissibility - (no) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t050725eu1.html
Date retrieved: 17 May 2021